Back to Search
Start Over
DAMPening COVID-19 Severity by Attenuating Danger Signals.
- Source :
-
Frontiers in immunology [Front Immunol] 2021 Aug 12; Vol. 12, pp. 720192. Date of Electronic Publication: 2021 Aug 12 (Print Publication: 2021). - Publication Year :
- 2021
-
Abstract
- COVID-19 might lead to multi-organ failure and, in some cases, to death. The COVID-19 severity is associated with a "cytokine storm." Danger-associated molecular patterns (DAMPs) are proinflammatory molecules that can activate pattern recognition receptors, such as toll-like receptors (TLRs). DAMPs and TLRs have not received much attention in COVID-19 but can explain some of the gender-, weight- and age-dependent effects. In females and males, TLRs are differentially expressed, likely contributing to higher COVID-19 severity in males. DAMPs and cytokines associated with COVID-19 mortality are elevated in obese and elderly individuals, which might explain the higher risk for severer COVID-19 in these groups. Adenosine signaling inhibits the TLR/NF-κB pathway and, through this, decreases inflammation and DAMPs' effects. As vaccines will not be effective in all susceptible individuals and as new vaccine-resistant SARS-CoV-2 mutants might develop, it remains mandatory to find means to dampen COVID-19 disease severity, especially in high-risk groups. We propose that the regulation of DAMPs via adenosine signaling enhancement might be an effective way to lower the severity of COVID-19 and prevent multiple organ failure in the absence of severe side effects.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Silva-Lagos, Pillay, van Meurs, Smink, van der Voort and de Vos.)
- Subjects :
- Adenosine metabolism
Alarmins antagonists & inhibitors
Animals
COVID-19 complications
COVID-19 immunology
COVID-19 therapy
Humans
Inflammation prevention & control
Inflammation Mediators antagonists & inhibitors
Multiple Organ Failure etiology
Multiple Organ Failure prevention & control
Patient Acuity
Signal Transduction
Toll-Like Receptors antagonists & inhibitors
Toll-Like Receptors immunology
Alarmins immunology
COVID-19 physiopathology
Inflammation Mediators immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1664-3224
- Volume :
- 12
- Database :
- MEDLINE
- Journal :
- Frontiers in immunology
- Publication Type :
- Academic Journal
- Accession number :
- 34456928
- Full Text :
- https://doi.org/10.3389/fimmu.2021.720192